Oxford Biomedica plc (LON:OXB – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 455 ($5.65) and last traded at GBX 444 ($5.51), with a volume of 467163 shares traded. The stock had previously closed at GBX 416 ($5.17).
Oxford Biomedica Stock Performance
The company’s 50-day moving average price is GBX 420.29 and its 200 day moving average price is GBX 388.15. The stock has a market capitalization of £435.14 million, a PE ratio of -286.81 and a beta of 1.09. The company has a debt-to-equity ratio of 154.88, a quick ratio of 1.67 and a current ratio of 2.35.
Oxford Biomedica Company Profile
One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.
Featured Stories
- Five stocks we like better than Oxford Biomedica
- What is the MACD Indicator and How to Use it in Your Trading
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Short Selling: How to Short a Stock
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Warren Buffett Stocks to Buy Now
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.